Healthcare stocks are cooling as hospitals grapple with rising uninsured patients, with HCA Healthcare warning of a $400 million profit hit. The ripple effect is hitting diverse players like Hims & Hers, Repligen, and West Pharmaceutical, sparking sharp declines. While today’s moves are steep, long-term investors in Hims & Hers still see strong gains—proof that volatility doesn’t always signal doom. The bigger picture? Financial strain on providers and access gaps for patients are reshaping the industry’s future.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
